Loading company…
ScreenPoint Medical develops AI software to assist with breast cancer detection in mammograms.
Founded in 2014 in the Netherlands, ScreenPoint Medical develops AI software for breast cancer detection. Its Transpara product uses deep learning to assist radiologists with 2D and 3D mammography readings and risk assessment. In April 2026, the company raised USD 14 million in venture funding from Insight Partners and Siemens Medical Solutions USA, Inc., as part of a larger USD 16 million venture and grant funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in